Drug Shortage Report for CIPRO ORAL SUSPENSION
Report ID | 142783 |
Drug Identification Number | 02237514 |
Brand name | CIPRO ORAL SUSPENSION |
Common or Proper name | Ciprofloxacin Suspension |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 10g/100mL |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-07-20 |
Estimated end date | Unknown |
Actual end date | 2021-07-22 |
Shortage status | Resolved |
Updated date | 2021-07-23 |
Company comments | Available now to market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-07-23 | English | Compare |
v3 | 2021-07-21 | English | Compare |
v2 | 2021-07-20 | French | Compare |
v1 | 2021-07-20 | English | Compare |
Showing 1 to 4 of 4